Clinical Trials Logo

Gastric Cancer clinical trials

View clinical trials related to Gastric Cancer.

Filter by:

NCT ID: NCT02892643 Completed - Gastric Cancer Clinical Trials

Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy

Start date: October 27, 2016
Phase: N/A
Study type: Interventional

Experimental: Laparoscopic proximal gastrectomy Laparoscopy proximal gastrectomy with esophago-jejunostomy, gastro-jejunostomy and jejuno-jejunostomy (double tract reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy. Active Comparator: Laparoscopic total gastrectomy Laparoscopic total gastrectomy with esophago-jejunostomy and jejuno-jejunostomy (Roux-en-Y reconstruction). Systemic en bloc lymph node dissection is mandatory. Resection margin should be negative for malignancy with intraoperative frozen biopsy.

NCT ID: NCT02853474 Completed - Gastric Cancer Clinical Trials

Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

EPIC-1511
Start date: October 2016
Phase: Phase 3
Study type: Interventional

This prospective, randomized, open-label and multicenter phase III study is aimed to estimate the survival benefit of Early Palliative Care (EPC) combined with standard oncology care including first-line chemotherapy (experimental arm) over standard oncology care only (standard arm), in patients with metastatic upper gastrointestinal cancers (gastric cancer, pancreatic cancer, biliary tract cancers).

NCT ID: NCT02852252 Completed - Gastric Cancer Clinical Trials

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

Start date: July 2016
Phase:
Study type: Observational [Patient Registry]

The study objective is to collect prospective data on cancer patients who undergo surgery and intraoperative imaging. The registry will include (but not limited to) cancer type, stage, intraoperative challenges to the surgeon, usage and results of intraoperative imaging, and recurrence surveillance.

NCT ID: NCT02848066 Completed - Gastric Cancer Clinical Trials

Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker

Start date: July 2015
Phase:
Study type: Observational

The purpose of this study is to evaluate sensitivity and specificity of newly defined tumor biomarker with gastric cancer pts and cancer-free healthy volunteers.

NCT ID: NCT02815150 Completed - Gastric Cancer Clinical Trials

Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer Patients

Start date: April 1, 2016
Phase: N/A
Study type: Interventional

This study aims to assess the impact of preoperative oral carbohydrate drink on gastric emptying and PH of gastric fluid in gastric cancer patients directly. Furthermore, investigators aim to evaluate the safety and effectiveness of preoperative oral carbohydrate in elective gastric cancer surgery, providing direct evidence for clinical practice.

NCT ID: NCT02810652 Completed - Pancreatic Cancer Clinical Trials

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to addresses the challenge of managing the unique perioperative needs of older cancer patients undergoing surgical resection.

NCT ID: NCT02796365 Completed - Breast Cancer Clinical Trials

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

HF-PROACTIVE
Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to identify patients at risk for future heart failure using novel markers of early cardiac damage and determine if exercise training can improve these emerging markers as well as overall fitness and quality of life.

NCT ID: NCT02789826 Completed - Gastric Cancer Clinical Trials

Laparoscopic Versus Open Resection of Cancer Stomach

Start date: June 2016
Phase: N/A
Study type: Interventional

The aim of surgical procedures for resection of cancer stomach is to resection of the tumor mass with safety margin and its drainage lymph nodes (lymphadenectomy). There are two main types of techniques (open & laparoscopic) Many studies were done comparing these two techniques showed that Laparoscopic resection is superior in early postoperative recovery (less pain ,less bleeding and shorter hospital stay) but less radical than open resection (less safety margin & less lymphadenectomy) but because of the ongoing advances on laparoscopic surgery these results needs more and more revision. So the investigators conduct this randomized controlled trial aiming at comparing open and laparoscopic resection of cancer stomach to choose the best surgical procedure for resection of cancer stomach.

NCT ID: NCT02764268 Completed - Gastric Cancer Clinical Trials

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

Start date: November 2, 2016
Phase: N/A
Study type: Interventional

Apatinib dose titration in Advanced or Metastatic Gastric Cancer

NCT ID: NCT02746796 Completed - Gastric Cancer Clinical Trials

Study of ONO-4538 in Gastric Cancer

Start date: March 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of study is to evaluate the efficacy and safety of ONO-4538 with chemotherapy in unresectable advanced or recurrent gastric cancer (including esophagogastric junction cancer) not previously treated with the first-line therapy. Part 1 is intended to evaluate the tolerability, safety, and efficacy of ONO-4538 in combination with SOX therapy (Tegafur / gimeracil / oteracil potassium + Oxaliplatin) or CapeOX therapy (Capecitabine + Oxaliplatin). In part 2, the investigator or the subinvestigator will choose a chemotherapy (SOX or CapeOX therapy), taking into account the condition of each subject. Part 2 is planned to evaluate the efficacy and safety of ONO-4538 + chemotherapy in comparison with placebo + chemotherapy.